Stents Bare Metal

Bare metal stents are mesh-like tubes of thin wire without a coating or covering. Ideally, bare metal stents will be covered by a new layer of endothelial cells, sealing it into the vessel wall, within a few weeks after implant. However, a percentage of patients have their body negatively respond to the implanted foreign body, resulting in the formation of neointimal hyperplasia, a growth of scar tissue over the stent. This can cause restenosis of the vessel segment, which led to the development of drug-eluting stents (DES) now used in most patients. However, DES require the patient to take long-term antiplatelet medication, so patients who are likely to be noncompliant are often given bare metal stents.  

The Medtronic Resolute Integrity drug-eluting stent is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data. Stent advances and new stent technologies.

The Medtronic Resolute Integrity drug-eluting stent (DES) is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data.

Feature | Stents | January 29, 2019 | Dave Fornell, Editor
There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years...
FDA Approves New Indication for NuMed CP Stent System
Technology | Stents Bare Metal | December 14, 2017
December 14, 2017 — The U.S. Food and Drug Administration (FDA) announced clearance for NuMed’s Cheatham Platinum (CP)...
News | Stents | November 10, 2017
November 10, 2017 — Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology...
Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal | September 22, 2017
September 22, 2017 — Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy...
Biotronik, PRO-Kinetic Energy cobalt chromium coronary stent system, FDA approval
Technology | Stents Bare Metal | February 15, 2017
February 15, 2017 — The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S....
Biotronik Astron stent
Technology | Stents Peripheral | December 31, 2015
December 31, 2015 - The U.S. Food and Drug Administration (FDA) has cleared Biotronik's Astron Peripheral Self-...
Technology | Stents Bare Metal | December 09, 2015
December 9, 2015 — Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the...
News | Antiplatelet and Anticoagulation Therapies | June 11, 2015
June 11, 2015 - Patients who received a bare metal coronary stent did not display significant differences in rates of...
Technology | July 22, 2014
July 22, 2014 — Boston Scientific announced it received U.S. Food and Drug Administration (FDA) approval for the Rebel...
Boston Scientific Rebel Platinum Chromium Coronary Stent System Bare Metal
News | March 13, 2014
March 13, 2014 — Boston Scientific Corp. received CE marking for the Rebel Platinum Chromium Coronary Stent System, the...
tryton stent, bifurcation stenting
Feature | November 01, 2013
November 1, 2013 — A clinical trial designed to measure the effectiveness of using a dedicated side branch-covering...
cath lab drug-eluting balloons stents bare metal clinical trial study RIBS V
Feature | November 01, 2013
November 1, 2013 — A clinical trial comparing the use of drug-eluting stents (DES) and drug-eluting balloons (DEB) in...
Biosensors BioMatrix

The LEADERS Trial showed that the Biosensors BioMatrix, a drug-eluting stent with a biodegradable abluminal polymer coating, was functionally equivalent to a regular nonbiodegradable stent.

Feature | February 04, 2013 | Kamran Zamanian, Ph.D.
The interventional cardiology market includes, but is not limited to, drug-eluting stents, bare-metal stents,...
News | December 27, 2012
December 27, 2012 — Biotronik announced that the first implant has taken place in the BIOHELIX-I trial in the United...
Tryton Side Branch Stent TRYTON Pivotal FDA IDE trial
Feature | December 07, 2012
December 7, 2012 — Tryton Medical Inc. announced the completion of enrollment in the TRYTON Pivotal U.S. Food and Drug...